Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abpro Holdings Inc. stock logo
ABP
Abpro
$0.52
$0.52
$0.52
▼
$29.97
$1.42MN/A5.06 million shsN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
$0.14
-14.3%		$0.18
$0.07
▼
$7.15
$896K0.6444,323 shs10,140 shs
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
$1.86
-4.6%		$2.56
$1.85
▼
$16.40
$1.01M2.08164,561 shs82,384 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$0.21
-5.8%		$0.24
$0.21
▼
$2.80
$374K0.42,596 shs16,067 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abpro Holdings Inc. stock logo
ABP
Abpro
0.00%0.00%0.00%0.00%-93.20%
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
-14.29%-0.28%+29.11%-73.27%+14,459,900.00%
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
-4.62%-25.90%-25.60%-54.89%-88.45%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-5.83%-5.83%-6.67%-38.24%-91.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abpro Holdings Inc. stock logo
ABP
Abpro
$0.52
$0.52
$0.52
▼
$29.97
$1.42MN/A5.06 million shsN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
$0.14
-14.3%		$0.18
$0.07
▼
$7.15
$896K0.6444,323 shs10,140 shs
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
$1.86
-4.6%		$2.56
$1.85
▼
$16.40
$1.01M2.08164,561 shs82,384 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$0.21
-5.8%		$0.24
$0.21
▼
$2.80
$374K0.42,596 shs16,067 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abpro Holdings Inc. stock logo
ABP
Abpro
0.00%0.00%0.00%0.00%-93.20%
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
-14.29%-0.28%+29.11%-73.27%+14,459,900.00%
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
-4.62%-25.90%-25.60%-54.89%-88.45%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-5.83%-5.83%-6.67%-38.24%-91.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abpro Holdings Inc. stock logo
ABP
Abpro
1.50
ReduceN/AN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
1.00
SellN/AN/A
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
1.00
SellN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest XAGE, ABP, SCNI, and BNBX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abpro Holdings Inc. stock logo
ABP
Abpro
N/AN/AN/AN/A($8.83) per shareN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
$2.09M0.43N/AN/A$1.50 per share0.10
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
$1.49M0.65N/AN/A$11.81 per share0.16
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$1.05M0.36N/AN/A($6.77) per share-0.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abpro Holdings Inc. stock logo
ABP
Abpro
-$7.23M-$4.23N/AN/AN/AN/AN/A-344.76%N/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
-$15.16M-$3.33N/AN/AN/A-1,647.25%-349.95%-283.96%N/A
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
-$8.31M-$95.34N/AN/AN/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-$10.37M-$3.49N/AN/AN/A-682.67%N/A-261.90%N/A

Latest XAGE, ABP, SCNI, and BNBX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q3 2026
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
N/A-$0.57N/A-$0.57N/A$0.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abpro Holdings Inc. stock logo
ABP
Abpro
N/AN/AN/AN/AN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
N/AN/AN/AN/AN/A
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
N/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abpro Holdings Inc. stock logo
ABP
Abpro
N/A
0.07
0.07
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
N/A
1.82
1.74
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
0.05
1.56
1.35
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A
0.47
0.30

Institutional Ownership

CompanyInstitutional Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
23.30%
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
22.22%
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
58.41%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
24.22%

Insider Ownership

CompanyInsider Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
13.70%
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
6.14%
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
60.90%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abpro Holdings Inc. stock logo
ABP
Abpro
152.72 million2.34 millionN/A
Applied Dna Sciences Inc stock logo
BNBX
Applied Dna Sciences
706.20 million6.76 millionN/A
Scinai Immunotherapeutics Ltd. Sponsored ADR stock logo
SCNI
Scinai Immunotherapeutics
20517,000202,000Not Optionable
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
141.78 million1.27 millionN/A

Recent News About These Companies

Longevity Health (NASDAQ:XAGE) Shares Down 5.8% - What's Next?
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31004029
Longevity Health Raises Capital via Secured Convertible Note
September 4 at 5:51 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-raises-capital-via-secured-convertible-note?utm_source=marketbeat.com&utm_medium=referral
Longevity Health Holdings Announces Settlement of Litigation with Puritan Partners LLC
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346173/0/en/longevity-health-holdings-announces-settlement-of-litigation-with-puritan-partners-llc.html
Longevity Health Announces Routine Board Member Resignation
June 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-announces-routine-board-member-resignation?utm_source=marketbeat.com&utm_medium=referral
Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)
March 27, 2026  |  defenseworld.netD
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
March 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/17/3257196/0/en/longevity-health-holdings-closes-strategic-investment-and-appoints-ram-ajjarapu-as-chairman-and-ceo-to-drive-acquisition-focused-growth.html
Longevity Health Holdings Ends Merger with True Health
December 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-holdings-ends-merger-with-true-health?utm_source=marketbeat.com&utm_medium=referral
Why Longevity Health Stock Is Skyrocketing Today
July 15, 2025  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/25/07/46430331/why-longevity-health-stock-is-skyrocketing-today
Why Longevity Health Stock Is Skyrocketing Today
July 15, 2025  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/25/07/46430331/why-longevity-health-stock-is-skyrocketing-today?utm_source=snapi
Why did XAGE Stock Surge in Today’s Premarket Trading?
July 15, 2025  |  tokenist.comT
Longevity Health Holdings, Inc.: Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
July 15, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65907064-longevity-health-holdings-inc-longevity-health-holdings-announces-merger-with-thplasma-and-termination-of-20-20-biolabs-transaction-399.htm
Longevity Health Holdings to Merge With True Health
July 15, 2025  |  marketwatch.comhttps://www.marketwatch.com/story/longevity-health-holdings-to-merge-with-true-health-5632aee0
Longevity Health stock soars after merger with THPlasma in all-stock deal
July 15, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/longevity-health-stock-soars-after-merger-with-thplasma-in-allstock-deal-93CH-4135554
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
July 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/14/3115204/0/en/Longevity-Health-Holdings-Announces-Merger-with-THPlasma-and-Termination-of-20-20-BioLabs-Transaction.html

Media Sentiment Over Time

Abpro stock logo

Abpro NASDAQ:ABP

$0.52 0.00 (0.00%)
As of 09/3/2026

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Applied Dna Sciences stock logo

Applied Dna Sciences NASDAQ:BNBX

$0.14 -0.02 (-14.29%)
As of 09/4/2026 01:02 PM Eastern

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Scinai Immunotherapeutics stock logo

Scinai Immunotherapeutics NASDAQ:SCNI

$1.86 -0.09 (-4.62%)
As of 09/4/2026 04:00 PM Eastern

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Longevity Health stock logo

Longevity Health NASDAQ:XAGE

$0.21 -0.01 (-5.83%)
As of 09/4/2026 11:26 AM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas